Chronic arsenic poisoning

被引:169
作者
Hall, AH [1 ]
机构
[1] Texas Tech Univ, Hlth Sci Ctr El Paso, Dept Emergency Med, Div Toxicol, El Paso, TX USA
[2] Toxicol Consulting & Med Translating Serv FACEP I, El Paso, TX 79936 USA
关键词
arsenic; poisoning; toxicity; chronic exposure;
D O I
10.1016/S0378-4274(01)00534-3
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
Symptomatic arsenic poisoning is not often seen in occupational exposure settings. Attempted homicide and deliberate long-term poisoning have resulted in chronic toxicity. Skin pigmentation changes. palmar and plantar hyperkeratoses. gastrointestinal symptoms, anemia. and liver disease are common. Noncirrhotic portal hypertension with bleeding esophageal varices, splenomegaly, and hypersplenism may occur. A metallic taste, gastrointestinal disturbances, and Mee's lines may be seen. Bone marrow depression is common. 'Blackfoot disease' has been associated with arsenic-contaminated drinking water in Taiwan; Raynaud's phenomenon and acrocyanosis also may occur. Large numbers of persons in areas of India. Pakistan, and several other countries have been chronically poisoned from naturally occurring arsenic in ground water, Toxic delirium and encephalopathy can be present. CCA-treated wood (chromated copper arsenate) is not a health risk unless burned in fireplaces or woodstoves. Peripheral neuropathy may also occur. Workplace exposure or chronic ingestion of arsenic-contaminated water or arsenical medications is associated with development of skin, lung, and other cancers. Treatment may include the use of chelating agents such as dimercaprol (BAL), dimercaptosuccinic acid (DMSA), and dimercaptopanesulfonic acid (DMPS). (C) 2002 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:69 / 72
页数:4
相关论文
共 25 条
[1]   Associations between drinking water and urinary arsenic levels and skin lesions in Bangladesh [J].
Ahsan, H ;
Perrin, M ;
Rahman, A ;
Parvez, F ;
Stute, M ;
Zheng, Y ;
Milton, AH ;
Brandt-Rauf, P ;
van Geen, A ;
Graziano, J .
JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE, 2000, 42 (12) :1195-1201
[2]  
*ATSDR, 1990, ATSDR CAS STUD ENV M
[3]   PHRENIC NEUROPATHY IN ARSENIC POISONING [J].
BANSAL, SK ;
HALDAR, N ;
DHAND, UK ;
CHOPRA, JS .
CHEST, 1991, 100 (03) :878-880
[4]   ARSENIC INGESTION AND INTERNAL CANCERS - A REVIEW [J].
BATES, MN ;
SMITH, AH ;
HOPENHAYNRICH, C .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1992, 135 (05) :462-476
[5]   CELLULAR UPTAKE AND METABOLIC REDUCTION OF PENTAVALENT TO TRIVALENT ARSENIC AS DETERMINANTS OF CYTOTOXICITY AND MORPHOLOGICAL TRANSFORMATION [J].
BERTOLERO, F ;
POZZI, G ;
SABBIONI, E ;
SAFFIOTTI, U .
CARCINOGENESIS, 1987, 8 (06) :803-808
[6]  
CHIOU HY, 1995, CANCER RES, V55, P1296
[7]   INGESTED ARSENIC, KERATOSES, AND BLADDER-CANCER [J].
CUZICK, J ;
SASIENI, P ;
EVANS, S .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1992, 136 (04) :417-421
[8]  
GOCHFELD M, 1995, ENV MED, P592
[9]  
Goddard M J, 1992, Electromyogr Clin Neurophysiol, V32, P419
[10]  
HATHAWAY GJ, 1991, PROCTOR HUGHES CHEM, P92